The efficacy of GIP(3-30)NH2 as a GIP receptor antagonist in humans: [Meeting Abstract}

Research output: Contribution to journalConference articleResearch

L. S. Gasbjerg, E. J. Bari, S. Stensen, B. Hoe, A. R. Lanng, D. S. Mathiesen, M. B. Christensen, B. Hartmann, J. J. Holst, M. M. Rosenkilde, F. K. Knop

Original languageEnglish
Article number557
JournalDiabetologia
Volume62
Issue numberSupæ. 1/SI
Pages (from-to)S269-S269
ISSN0012-186X
Publication statusPublished - 2019
Event55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) - Barcelona, Spain
Duration: 16 Sep 201920 Sep 2019

Conference

Conference55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
CountrySpain
CityBarcelona
Period16/09/201920/09/2019

ID: 230571329